May 1, 2016

“How 2015’s Patent Law Trends Will Affect Life Sciences Companies,” Life Science Leader, May 1, 2016

By Gregory S. DeLassus, Associate

Although 2015 did not produce any explosive new developments in patent law from the Supreme Court (like the Myriad gene patenting case in 2013) or from Congress (like the America Invents Act in 2012, also known as the AIA), the past year did witness the emergence of two important trends in life sciences patent law. These trends concern: (1) increasingly difficult standards for life sciences inventions to be considered eligible subject matter for patenting; and (2) low cost, expedited procedures to contest patent validity after grant.

Read full article.